echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Blood: EMT regulator SNAI1 promotes AML progress through interaction with LSD1

    Blood: EMT regulator SNAI1 promotes AML progress through interaction with LSD1

    • Last Update: 2020-05-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In recent years, the regulatory factors of epithelial-interstitial transformation (EMT) have become new members of the field of leukemia biologyHowever, the mechanism by which EMT regulatory factors are involved in the onset of leukemia is not completely clearin this study
    , Carmichael et alfound that a key regulatory factor of EMT, SNAI1, is a pathologically related event in human acute myeloid leukemia (AML), which can lead to impaired differentiation, self-renewal, and proliferation of immature myelin cellsin addition, the researchers also demonstrated in mice that allogeneic expression in hematopoietic cells can lead to the development of acute myeloid leukemiaThis action is mediated by interaction with histone demethylase KDM1A/LSD1this study reveals the new role of SNAI1 in the development of leukemia and identifies new mechanisms for the destruction of LSD1 in cancerThis is particularly important in view of the current interest in LSD1 inhibitors in the treatment of many different malignancies, including AML
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.